102 related articles for article (PubMed ID: 12742624)
21. Pharmacological and immunological identification of native alpha7 nicotinic receptors: evidence for homomeric and heteromeric alpha7 receptors.
El-Hajj RA; McKay SB; McKay DB
Life Sci; 2007 Sep; 81(16):1317-22. PubMed ID: 17928008
[TBL] [Abstract][Full Text] [Related]
22. The comparative pharmacology and up-regulation of rat neuronal nicotinic receptor subtype binding sites stably expressed in transfected mammalian cells.
Xiao Y; Kellar KJ
J Pharmacol Exp Ther; 2004 Jul; 310(1):98-107. PubMed ID: 15016836
[TBL] [Abstract][Full Text] [Related]
23. Carbamoylcholine homologs: novel and potent agonists at neuronal nicotinic acetylcholine receptors.
Jensen AA; Mikkelsen I; Frølund B; Bräuner-Osborne H; Falch E; Krogsgaard-Larsen P
Mol Pharmacol; 2003 Oct; 64(4):865-75. PubMed ID: 14500743
[TBL] [Abstract][Full Text] [Related]
24. Characterization of (+/-)(-)[3H]epibatidine binding to nicotinic cholinergic receptors in rat and human brain.
Houghtling RA; Dávila-García MI; Kellar KJ
Mol Pharmacol; 1995 Aug; 48(2):280-7. PubMed ID: 7651361
[TBL] [Abstract][Full Text] [Related]
25. Norchloro-fluoro-homoepibatidine: specificity to neuronal nicotinic acetylcholine receptor subtypes in vitro.
Deuther-Conrad W; Patt JT; Feuerbach D; Wegner F; Brust P; Steinbach J
Farmaco; 2004 Oct; 59(10):785-92. PubMed ID: 15474055
[TBL] [Abstract][Full Text] [Related]
26. Neuronal nicotinic receptor beta2 and beta4 subunits confer large differences in agonist binding affinity.
Parker MJ; Beck A; Luetje CW
Mol Pharmacol; 1998 Dec; 54(6):1132-9. PubMed ID: 9855644
[TBL] [Abstract][Full Text] [Related]
27. α-Conotoxins Identify the α3β4* Subtype as the Predominant Nicotinic Acetylcholine Receptor Expressed in Human Adrenal Chromaffin Cells.
Hone AJ; McIntosh JM; Azam L; Lindstrom J; Lucero L; Whiteaker P; Passas J; Blázquez J; Albillos A
Mol Pharmacol; 2015 Nov; 88(5):881-93. PubMed ID: 26330550
[TBL] [Abstract][Full Text] [Related]
28. Nicotinic receptor activation by epibatidine induces heme oxygenase-1 and protects chromaffin cells against oxidative stress.
Egea J; Rosa AO; Cuadrado A; García AG; López MG
J Neurochem; 2007 Sep; 102(6):1842-1852. PubMed ID: 17540012
[TBL] [Abstract][Full Text] [Related]
29. Characterization of human alpha 4 beta 2-nicotinic acetylcholine receptors stably and heterologously expressed in native nicotinic receptor-null SH-EP1 human epithelial cells.
Eaton JB; Peng JH; Schroeder KM; George AA; Fryer JD; Krishnan C; Buhlman L; Kuo YP; Steinlein O; Lukas RJ
Mol Pharmacol; 2003 Dec; 64(6):1283-94. PubMed ID: 14645658
[TBL] [Abstract][Full Text] [Related]
30. Deletion of the alpha7, beta2, or beta4 nicotinic receptor subunit genes identifies highly expressed subtypes with relatively low affinity for [3H]epibatidine.
Marks MJ; Whiteaker P; Collins AC
Mol Pharmacol; 2006 Sep; 70(3):947-59. PubMed ID: 16728647
[TBL] [Abstract][Full Text] [Related]
31. Effects of nonylphenol on the calcium signal and catecholamine secretion coupled with nicotinic acetylcholine receptors in bovine adrenal chromaffin cells.
Liu PS; Liu GH; Chao WL
Toxicology; 2008 Feb; 244(1):77-85. PubMed ID: 18093714
[TBL] [Abstract][Full Text] [Related]
32. Receptor protection studies to characterize neuronal nicotinic receptors: tubocurarine prevents alkylation of adrenal nicotinic receptors.
Free RB; McKay DB
Brain Res; 2001 Feb; 891(1-2):176-84. PubMed ID: 11164821
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological differences between immunoisolated native brain and heterologously expressed rat alpha4beta2 nicotinic receptors.
Truong A; Xing X; Forsayeth JR; Dwoskin LP; Crooks PA; Cohen BN
Brain Res Mol Brain Res; 2001 Nov; 96(1-2):68-76. PubMed ID: 11731010
[TBL] [Abstract][Full Text] [Related]
34. Regional distribution of subtypes of nicotinic receptors in human brain and effect of aging studied by (+/-)-[3H]epibatidine.
Marutle A; Warpman U; Bogdanovic N; Nordberg A
Brain Res; 1998 Aug; 801(1-2):143-9. PubMed ID: 9729344
[TBL] [Abstract][Full Text] [Related]
35. Evidence for constitutive expression of bovine adrenal a3beta4* nicotinic acetylcholine receptors.
Free RB; McKay SB; Boyd RT; McKay DB
Ann N Y Acad Sci; 2002 Oct; 971():145-7. PubMed ID: 12438106
[TBL] [Abstract][Full Text] [Related]
36. Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors.
Gerzanich V; Peng X; Wang F; Wells G; Anand R; Fletcher S; Lindstrom J
Mol Pharmacol; 1995 Oct; 48(4):774-82. PubMed ID: 7476906
[TBL] [Abstract][Full Text] [Related]
37. Characterization of nicotinic acetylcholine receptors on cultured bovine adrenal chromaffin cells using modified L-[3H]nicotine binding assay.
Lee K; Miwa S; Koshimura K; Ito A
Naunyn Schmiedebergs Arch Pharmacol; 1992 Apr; 345(4):363-9. PubMed ID: 1620238
[TBL] [Abstract][Full Text] [Related]
38. Butyl benzyl phthalate blocks Ca2+ signaling and catecholamine secretion coupled with nicotinic acetylcholine receptors in bovine adrenal chromaffin cells.
Liu PS; Lin CM; Pan CY; Kao LS; Tseng FW
Neurotoxicology; 2003 Jan; 24(1):97-105. PubMed ID: 12564386
[TBL] [Abstract][Full Text] [Related]
39. Identification of a novel nicotinic binding site in mouse brain using [(125)I]-epibatidine.
Whiteaker P; Jimenez M; McIntosh JM; Collins AC; Marks MJ
Br J Pharmacol; 2000 Oct; 131(4):729-39. PubMed ID: 11030722
[TBL] [Abstract][Full Text] [Related]
40. Rat alpha3/beta4 subtype of neuronal nicotinic acetylcholine receptor stably expressed in a transfected cell line: pharmacology of ligand binding and function.
Xiao Y; Meyer EL; Thompson JM; Surin A; Wroblewski J; Kellar KJ
Mol Pharmacol; 1998 Aug; 54(2):322-33. PubMed ID: 9687574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
